Investors & Media

Transformative science, targeted medicines

We are working to advance a deep pipeline of precision therapies, designed to allow patients to live longer, better lives. Our approach combines world-leading expertise in protein kinases with sound execution and an intense focus on discovery.

SEC Filings

SEC Filings

Filing date	Form	Description	View
Feb 17, 2021	S-8	Securities offered to employees pursuant to employee benefit plans	View HTML 0001558370-21-001147.pdf 0001558370-21-001147.rtf 0001558370-21-001147.xls
Feb 16, 2021	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000080255-21-001228.pdf 0000080255-21-001228.rtf
Feb 11, 2021	UPLOAD	UPLOAD	View HTML 0000000000-21-001734.pdf 0000000000-21-001734.rtf
Feb 10, 2021	SC 13G/A	An amendment to the SC 13G filing	View HTML 0001104659-21-017599.pdf 0001104659-21-017599.rtf
Feb 08, 2021	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000315066-21-000872.pdf 0000315066-21-000872.rtf
Feb 03, 2021	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000902219-21-000079.pdf 0000902219-21-000079.rtf 0000902219-21-000079.xls
Jan 29, 2021	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000834237-21-002930.pdf 0000834237-21-002930.rtf
Jan 19, 2021	3	Initial filing by director officer or owner of more than ten percent.	View HTML 0001179110-21-000686.pdf 0001179110-21-000686.rtf 0001179110-21-000686.xls
Jan 14, 2021	CORRESP	CORRESP	View HTML 0001558370-21-000203.pdf 0001558370-21-000203.rtf
Jan 11, 2021	8-K	Report of unscheduled material events or corporate event	View HTML 0001558370-21-000147.pdf 0001558370-21-000147.rtf 0001558370-21-000147.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Continue